GLP1R and type 2 diabetes mellitus: The ongoing integration of genomics, transcriptomics, proteomics, metabolomics, and other omics technologies promises to refine GLP-1 based T2DM strategies through detailed characterization of L cell subtypes and gene regulatory networks etc (22, 23).